PINK COPYRIGHT: A GROWING DANGER?

A concerning development is surfacing within the drug scene: "Pink copyright," formally known as Flunitramadol. This manufactured opioid is being marketed as a pill, often packaged as copyright, posing a significant risk to individuals . Its seemingly low expense and simple accessibility are fuel